ES2496946T3 - Derivados de nucleótidos de purina - Google Patents

Derivados de nucleótidos de purina Download PDF

Info

Publication number
ES2496946T3
ES2496946T3 ES05755520.3T ES05755520T ES2496946T3 ES 2496946 T3 ES2496946 T3 ES 2496946T3 ES 05755520 T ES05755520 T ES 05755520T ES 2496946 T3 ES2496946 T3 ES 2496946T3
Authority
ES
Spain
Prior art keywords
cyclic
mmol
adenosine
nmr
ampsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05755520.3T
Other languages
English (en)
Spanish (es)
Inventor
Kjell Undheim
Kjetil TASKÉN
Jo Klaveness
Geir Langli
Vidar BJØRNSTAD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvell AS
Original Assignee
Solvell AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvell AS filed Critical Solvell AS
Application granted granted Critical
Publication of ES2496946T3 publication Critical patent/ES2496946T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES05755520.3T 2004-06-18 2005-06-20 Derivados de nucleótidos de purina Expired - Lifetime ES2496946T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0413726 2004-06-18
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds
PCT/GB2005/002418 WO2005123755A2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives

Publications (1)

Publication Number Publication Date
ES2496946T3 true ES2496946T3 (es) 2014-09-22

Family

ID=32750205

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05755520.3T Expired - Lifetime ES2496946T3 (es) 2004-06-18 2005-06-20 Derivados de nucleótidos de purina

Country Status (10)

Country Link
US (1) US8153609B2 (enExample)
EP (1) EP1765844B1 (enExample)
JP (1) JP5044750B2 (enExample)
CN (1) CN101001865A (enExample)
AU (1) AU2005254790B2 (enExample)
CA (1) CA2568907C (enExample)
DK (1) DK1765844T3 (enExample)
ES (1) ES2496946T3 (enExample)
GB (1) GB0413726D0 (enExample)
WO (1) WO2005123755A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
GB0618235D0 (en) 2006-09-15 2006-10-25 Lauras As Process
EP2448968B1 (en) * 2009-06-29 2021-01-27 BioArctic AB ANTIBODIES SELECTIVE FOR N-TERMINALTRUNCATED AMYLOID-p PROTOFIBRILS/OLIGOMERS
EA025341B1 (ru) 2010-09-22 2016-12-30 Алиос Биофарма, Инк. Замещенные аналоги нуклеотидов
AU2011349278C1 (en) * 2010-12-22 2017-01-19 Alios Biopharma, Inc. Cyclic nucleotide analogs
EP2794627B1 (en) 2011-12-22 2018-09-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013096680A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
NZ630805A (en) 2012-03-22 2016-01-29 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
WO2022216577A1 (en) * 2021-04-09 2022-10-13 Merck Sharp & Dohme Llc Novel forms of cyclic dinucleotide compounds
WO2023031481A1 (en) 2021-09-06 2023-03-09 Mireca Medicines Gmbh Improved methods for production of cyclic guanosine-monophosphate analogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968101A (en) 1974-12-20 1976-07-06 Icn Pharmaceuticals, Inc. 8-Substituted cyclic nucleotides by free radical alkylation and acylation
WO1989007108A1 (en) * 1988-02-01 1989-08-10 Bernd Jastorff Process for producing nucleoside-3',5'-cyclophosphates and nucleoside-3',5'-cyclothiophosphates
AU4226693A (en) 1992-05-01 1993-11-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Phosphorothioate derivatives of cyclic AMP analogues
US5625056A (en) * 1992-05-26 1997-04-29 Biolog Life Science Institute Derivatives of cyclic guanosine-3',5'-monophosphorothioate
NO971997D0 (no) 1997-04-29 1997-04-29 Kjetil Tasken Bruk av immunmodulerende midler
CA2488611C (en) * 2002-06-07 2011-11-15 Kylix, B.V. Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)

Also Published As

Publication number Publication date
CA2568907A1 (en) 2005-12-29
AU2005254790B2 (en) 2012-02-23
GB0413726D0 (en) 2004-07-21
EP1765844A2 (en) 2007-03-28
JP2008502673A (ja) 2008-01-31
DK1765844T3 (da) 2014-09-01
AU2005254790A1 (en) 2005-12-29
CA2568907C (en) 2015-06-09
WO2005123755A2 (en) 2005-12-29
US20080293665A1 (en) 2008-11-27
CN101001865A (zh) 2007-07-18
JP5044750B2 (ja) 2012-10-10
WO2005123755A3 (en) 2006-04-06
US8153609B2 (en) 2012-04-10
EP1765844B1 (en) 2014-07-30

Similar Documents

Publication Publication Date Title
JP7158428B2 (ja) リボシドの調製のための方法
ES3039965T3 (en) Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
EP3013340B1 (en) Substituted nucleosides, nucleotides and analogs thereof
EP2609923B1 (en) Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
KR102363946B1 (ko) HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드
JP6646668B2 (ja) 抗がん性化合物としての新規な２’および／または５’アミノ酸エステルホスホロアミダート３’−デオキシアデノシン誘導体
ES2496946T3 (es) Derivados de nucleótidos de purina
US20100137576A1 (en) 5' o [(n acyl)amidophosphate] and 5' o [(n acyl)amidothiophosphate] and 5' o [(n acyl)amidodithiophosphate] and 5' o [(n acyl)amidoselenophosphate] derivatives of nucleosides and processes for the manufacture thereof
KR20030022295A (ko) 포스포네이트 뉴클레오티드 유사체의 전구약물과 그것의선택 및 제조 방법
KR20060008297A (ko) 2'-데옥시-β-Ｌ-뉴클레오시드의 제조방법
WO2021098379A1 (zh) 苯丙氨酸酰胺化的核苷酸衍生物及其制备方法与应用
EP3820879B1 (en) Phosphorus-containing prodrugs of gemcitabine
CN1812995A (zh) 工业化规模的核苷合成
CN111836823A (zh) β修饰磷酸化合物前体、β修饰磷酸化合物、反应阻碍剂和包含这些化合物的医药品以及反应阻碍方法
Piperno et al. Recent highlights in the synthesis of anti-HCV ribonucleosides
EP0799834A1 (en) Modified nucleotides
Perlíková Synthesis of novel cytostatic deazapurine nucleosides and pronucleotides
HK40069170A (en) Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
HK1182938B (en) Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
TW201210602A (en) Phosphorus-containing prodrugs and their therapeutic use